Participate in drug discovery program teams where you will design, conduct, interpret, and present the results of in vivo preclinical studies thus making important contributions to the drug discovery and translational medicine efforts in support of TCT RU programs.
Build understanding and contribute to in vivo pharmacology for oncology drug discovery.
Acquire practical experience conducting in vivo pharmacology studies (in vivo tumor model development, maximum tolerated dose (MTD), PK/PD relationship and efficacy) in mouse tumor models.
Mature public speaking through presentation of experimental design, methods, and findings.
Summarize key scientific findings in regulatory reports and manuscripts.
Partner and communicate with a wide range of internal and external stakeholders.
Build leadership skills.
BS or MS with 1+ years of relevant industry or academic experience in in vivo oncology research
Excellent mouse handling, dosing, caliper tumor measurements, and tissue sampling skills enabling the ability to independently conduct in vivo studies assessing tumor growth, efficacy, and PK/PD of pharmacological agents in xenograft models
Attention to detail and proficient reasoning skills in experimental design, data analysis, and interpretation
Experience in adopting new methods and protocols related to in vivo and ex vivo experiments
Highly motivated with excellent communication skills and demonstrated ability to work in a matrix team environment
Problem-solving abilities, be resourceful, be able to work in a fast-paced team environment, and be flexible about the role
Experience with syngeneic, orthotopic and/or humanized tumor models preferred
Experience with ex vivo tissue processing and aseptic cell culture technique (human and murine primary or/and cancer cell lines) preferred